PT-141, also known by the generic name bremelanotide, is a synthetic peptide used to treat sexual dysfunction in both men and women. Unlike traditional erectile dysfunction (ED) medications like Viagra or Cialis, which primarily increase blood flow (PDE-5 inhibitors), PT-141 works directly on the central nervous system by activating melanocortin receptors (MC3R and MC4R) in the brain to increase libido and sexual desire.
In 2019, the U.S. Food and Drug Administration (FDA) approved bremelanotide (under the brand name Vyleesi) for the treatment of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Its use for ED in men is considered off-label.
Key Details and Mechanism
Mechanism of Action: As a melanocortin agonist, PT-141 acts on the brain's neurochemical pathways to enhance sexual arousal, motivation, and desire, rather than just the physical mechanics of blood flow.
Administration: It is administered via subcutaneous injection (under the skin), typically in the abdomen or thigh, or as a nasal spray.
Onset and Duration: Effects usually begin within 30 to 60 minutes, with results lasting up to 12 hours or longer for some users.
Usage Limits: It is generally recommended to take no more than one dose per 24 hours, and a maximum of eight doses per month.
Benefits
Increased Desire & Libido: It effectively boosts sexual desire in women with HSDD.
Erectile Dysfunction Support: For men, it can help treat ED, particularly cases that do not respond to traditional phosphodiesterase type 5 (PDE-5) inhibitors.
Reduced Performance Anxiety: By increasing desire, it can help reduce anxiety related to sexual performance.
Non-Hormonal: It does not change testosterone or estrogen levels, making it a suitable option for those who cannot undergo hormone therapy.
Side Effects and Risks
Common Side Effects: The most common side effects include nausea (sometimes severe), flushing, and headaches.
Blood Pressure: It can cause a temporary, transient increase in blood pressure and a decrease in heart rate after each dose.
Skin Irritation: Mild to moderate irritation, redness, or pain at the injection site may occur.
Contraindications: Individuals with uncontrolled hypertension or cardiovascular disease should avoid taking PT-141.
Other Potential Issues: Long-term safety data is still being studied, and there is a possibility of developing tolerance to the medication over time.
Important Considerations
Medical Supervision: It is essential to consult with a healthcare professional to determine if PT-141 is safe for your specific health profile.
Off-Label Use: While used for men in clinical studies and private clinics, it is not officially FDA-approved for male erectile dysfunction.
Online Sources: Products labeled "research only" online are unregulated, and it is advised to obtain the medication via a legitimate prescription.
Disclaimer: This information is for educational purposes only based on search results and does not constitute medical advice.
PEPTIDES AREA NON-REFUNDABLE. PLEASE MAKE YOUR SELECTION CAREFULLY